A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study
Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis
SULFATION OF WNT PATHWAY PROTEINS
The Wnt/Ca2+ pathway
Inhibitor protein of the wnt signal pathway
INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY
The Wnt pathway 2
The Wnt pathway 1
WNT PATHWAY INHIBITORS